Your browser doesn't support javascript.
loading
The Correlation Between Serum Copper and Non-alcoholic Fatty Liver Disease in American Adults: an Analysis Based on NHANES 2011 to 2016.
Li, Lurao; Yi, Yun; Shu, Xiawen; Li, Jianghui; Kang, Hui; Chang, Ying.
Afiliação
  • Li L; Department of Gastroenterology, Zhong Nan Hospital of Wuhan University, Wuhan, China.
  • Yi Y; Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Diseases, Wuhan, China.
  • Shu X; Department of Gastroenterology, Zhong Nan Hospital of Wuhan University, Wuhan, China.
  • Li J; Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Diseases, Wuhan, China.
  • Kang H; Department of Gastroenterology, Zhong Nan Hospital of Wuhan University, Wuhan, China.
  • Chang Y; Hubei Clinical Center and Key Laboratory of Intestinal and Colorectal Diseases, Wuhan, China.
Biol Trace Elem Res ; 2024 Jan 03.
Article em En | MEDLINE | ID: mdl-38168830
ABSTRACT
Copper functions as an essential micronutrient influencing diverse metabolic processes in mammals, encompassing oxidative stress responses, lipid metabolism, and participation in enzymatic reactions. However, the impact of serum copper on non-alcoholic fatty liver disease (NAFLD) remains controversial. Our aim was to explore the precise correlation between serum copper and NAFLD in a large-scale population-based study. A total of 1377 participants from the National Health and Nutrition Examination Survey (NHANES) 2011-2016 were included in our study. The diagnosis of NAFLD and its progress to advanced liver fibrosis were based on serological indexes. One-way ANOVA, Kruskal-Wallis H test, and Chi-square test were used to access variations between quartiles groups of serum copper. We conducted multivariate-adjusted logistic regression models and subgroup analyses to investigate the association between serum copper and NAFLD, along with several metabolic diseases. Among the 1377 participants, 661 were diagnosed with NAFLD, and 141 of whom were classified into advanced liver fibrosis. Higher serum copper levels (≥ 21.00 µmol/L) were associated with an increased incidence of NAFLD (odds ratio (OR) = 2.07 (1.38-3.10), p < 0.001), as well as advanced liver fibrosis (OR = 2.40 (1.17-5.19), p = 0.025). Moreover, serum copper exhibited a positive correlation with hypertension, overweight, and abdominal obesity, all of which have been identified as risk factors of NAFLD. Additionally, female participants, under the age of 60, and with a higher body mass index (BMI) (> 24.9 kg/m2) emerged as the most vulnerable subgroup concerning the relationship between serum copper and NAFLD. In the U.S. population, a notable association has been identified, linking elevated serum copper to an increased susceptibility for both the onset and progression of NAFLD, along with several metabolic disorders associated with NAFLD. The adverse effects of excess copper warrant attention in the context of public health considerations.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biol Trace Elem Res Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biol Trace Elem Res Ano de publicação: 2024 Tipo de documento: Article